BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 38539508)

  • 1. Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease.
    Qattan A
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting molecular cross-talk between tumor cells and tumor associated macrophage as therapeutic strategy in triple negative breast cancer.
    Shettigar A; Salunke R; Modi D; Mukherjee N
    Int Immunopharmacol; 2023 Jun; 119():110250. PubMed ID: 37163922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Retrospective View of the Triple-Negative Breast Cancer Microenvironment: Novel Markers, Interactions, and Mechanisms of Tumor-Associated Components Using Public Single-Cell RNA-Seq Datasets.
    Kim M; Yang W; Hong D; Won HS; Yoon S
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple-negative breast cancer.
    Guo S; Liu X; Zhang J; Huang Z; Ye P; Shi J; Stalin A; Wu C; Lu S; Zhang F; Gao Y; Jin Z; Tao X; Huang J; Zhai Y; Shi R; Guo F; Zhou W; Wu J
    Comput Biol Med; 2023 Jul; 161():107066. PubMed ID: 37263064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research and experimental verification on the mechanisms of cellular senescence in triple-negative breast cancer.
    Cao T; Huang M; Huang X; Tang T
    PeerJ; 2024; 12():e16935. PubMed ID: 38435998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer.
    Chen X; Li Z; Liang M; Zhang Z; Zhu D; Lin B; Zhou R; Lu Y
    World J Surg Oncol; 2023 Jun; 21(1):194. PubMed ID: 37391802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling Heterogeneity of Tumor Cells and Microenvironment and Its Clinical Implications for Triple Negative Breast Cancer.
    Jiang K; Dong M; Li C; Sheng J
    Front Oncol; 2021; 11():557477. PubMed ID: 33854958
    [No Abstract]   [Full Text] [Related]  

  • 8. Landscape of toll-like receptors expression in tumor microenvironment of triple negative breast cancer (TNBC): Distinct roles of TLR4 and TLR8.
    Roychowdhury A; Jondhale M; Saldanha E; Ghosh D; Kumar Panda C; Chandrani P; Mukherjee N
    Gene; 2021 Aug; 792():145728. PubMed ID: 34022297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the heterogeneity of cancer-associated fibroblasts in TNBC.
    Wu X; Lu W; Zhang W; Zhang D; Mei H; Zhang M; Cui Y; Zhuo Z
    Aging (Albany NY); 2023 Nov; 15(21):12674-12697. PubMed ID: 37963845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a gene expression signature associated with breast cancer survival and risk that improves clinical genomic platforms.
    Bueno-Fortes S; Berral-Gonzalez A; Sánchez-Santos JM; Martin-Merino M; De Las Rivas J
    Bioinform Adv; 2023; 3(1):vbad037. PubMed ID: 37096121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients.
    Reimer F; Bryan S; Legler K; Karn T; Eppenberger-Castori S; Matschke J; Pereira-Veiga T; Wikman H; Witzel I; Müller V; Schmalfeldt B; Milde-Langosch K; Schumacher U; Stürken C; Oliveira-Ferrer L
    Cancer Cell Int; 2023 Mar; 23(1):47. PubMed ID: 36927383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Infiltrating Lymphocytes across Breast Cancer Subtypes: Current Issues for Biomarker Assessment.
    Valenza C; Taurelli Salimbeni B; Santoro C; Trapani D; Antonarelli G; Curigliano G
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchical cell-type identifier accurately distinguishes immune-cell subtypes enabling precise profiling of tissue microenvironment with single-cell RNA-sequencing.
    Lee J; Kim M; Kang K; Yang CS; Yoon S
    Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36681937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures.
    Li J; Wu J; Han J
    Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSEApy: a comprehensive package for performing gene set enrichment analysis in Python.
    Fang Z; Liu X; Peltz G
    Bioinformatics; 2023 Jan; 39(1):. PubMed ID: 36426870
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.